62 results on '"Park, Jae H"'
Search Results
2. Impact of Tocilizumab on CAR-T Cells Outcome and Toxicity: Results from a Large B Cell Lymphoma Cohort
3. Site-Specific Response Rates in Large B-Cell Lymphomas Treated with CD19-CART Therapy.
4. Cooperative CAR targeting to selectively eliminate AML and minimize escape
5. Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology
6. Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia
7. Subgroup Analyses of Kte-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Adult Patients (Pts) with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in Zuma-3
8. Poster: ALL-269 Safety and Pharmacokinetics of Calaspargase Pegol in Adults With Newly Diagnosed Philadelphia-Negative Acute Lymphoblastic Leukemia: A Phase 2/3 Study
9. Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
10. Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy
11. Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies
12. Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
13. Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos)–associated distinct purpuric subtype of toxic erythema of chemotherapy: A retrospective review of 54 patients
14. Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
15. Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
16. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
17. Phosphatidylserine synthase plays an essential role in glia and affects development, as well as the maintenance of neuronal function
18. Evolution of the American Board of Orthodontics scenario-based clinical examination
19. Managing older adults with Ph-negative ALL: What is new? Recent advances in treating older adults with ALL
20. Bridging Chemotherapy Prior to CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
21. Programmed cell death reshapes the central nervous system during metamorphosis in insects
22. Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial
23. Knock-in mutations of scarecrow, a Drosophila homolog of mammalian Nkx2.1, reveal a novel function required for development of the optic lobe in Drosophila melanogaster
24. Hematopoietic Recovery Following Chimeric Antigen Receptor T Cell (CAR T) Therapy in Hematological Malignancies
25. Trial in Progress: A Phase 2, Single-Arm, Open-Label Study of Itacitinib (ITA) for the Prevention of Chimeric Antigen Receptor (CAR) T-Cell–Induced Cytokine Release Syndrome (CRS)
26. Comparing Car T Cells Toxicities Grading Systems: Application of Astct Grading System and Implications for Management
27. Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
28. BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
29. Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart
30. Prediction of toxicity in R/R DLBCL treated with Axicabtagene Clioleucel (19-28z CAR T)
31. Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsules
32. Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
33. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
34. Mutations of the Gongpo Gene Encoding a Homolog of Mammalian Phosphatidylserine Synthases Cause Neurodegeneration in Drosophila Melanogaster
35. Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy
36. Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemia
37. Molybdenum oxide/carbon composites derived from the CO2 oxidation of Mo2CTx (MXene) for lithium ion battery anodes
38. Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia
39. Cloning and functional characterizations of an apoptogenic Hid gene in the Scuttle Fly, Megaselia scalaris (Diptera; Phoridae)
40. The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance
41. Hairy cell leukemia: Past, present and future
42. 475. Phase I Clinical Trial of Autologous CD19-Targeted 19-28z CAR T Cells in Adult Patients With Relapsed or Refractory B-ALL
43. Does the type of skin replacement surgery influence the rate of infection in acute burn injured patients?
44. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death
45. All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129
46. Characterization, expression, and evolutionary aspects of Corazonin neuropeptide and its receptor from the House Fly, Musca domestica (Diptera: Muscidae)
47. Cellular Therapies in Acute Lymphoblastic Leukemia
48. Curing All Patients with Acute Promyelocytic Leukemia: Are We There Yet?
49. Protective effect of quercetin against paraquat-induced lung injury in rats
50. Alleviation of dimethylnitrosamine-induced liver injury and fibrosis by betaine supplementation in rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.